Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases

By L. Adams, Q. Anstee, Herbert Tilg, G. Targher. Gut, 2017

1,030 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Surgery

View Paper: https://www.semanticscholar.org/paper/c1d9bb4e7882194f8435cb0cd3f260afb36fd372

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. G. Targher
2. A. Lonardo
3. Fabio Nascimbeni
4. A. Mantovani
5. Christopher D. Byrne

In Epidemiology

1. G. Targher
2. A. Lonardo
3. Fabio Nascimbeni
4. A. Mantovani
5. P. Tveden‐Nyborg
6. D. H. Ipsen
7. J. Lykkesfeldt
8. Christopher D. Byrne

In Surgery

1. G. Targher

Citations in the corpus

• Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence? (2018, background): “The validation of NAFLD as an independent risk factor would have direct relevance for primary preventive strategies against CVD. NAFLD increases risk of CVD An initial description of a significant association between NAFLD and the risk of incident CVD was published in the early 2000s.”
• NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications (2020, neutral): “10 Importantly, these associations are especially relevant in patients with NASH, suggesting that liver inflammation may directly contribute to the development of these extrahepatic diseases.”
• Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease (2018, background): “NAFLD is associated with increased mortality, particularly due to cardiovascular disease, hepatocellular carcinoma, and liverrelated events [4].”